The FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19. Read the full article here.